Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

Recent findings published in Scientific Reports highlight a promising target for ovarian cancer drug development, emphasizing ...

Germline pathogenic variants (gPVs) occur in a subset of patients with ovarian cancer, with the highest prevalence among those with Ashkenazi Jewish ancestry, followed by Asian and Hispanic patients, ...

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

The mDETECT blood test is advancing into the next phase of development thanks to an investment from Ovarian Cancer Canada You can save this article by registering for free here. Or sign-in if you have ...

Mirvetuximab soravtansine (MIRV; Elahere; AbbVie) demonstrated significant efficacy and an acceptable safety profile in the treatment of recurrent ovarian cancer, showing particular promise in ...

FRIDAY, Dec. 13, 2024 (HealthDay News) -- It's a decision no woman wants to have to make, but new research shows that young breast cancer patients with high-risk genes may be able to prevent their ...

While a common misconception about endometriosis is that it is simply a "menstruation disease," EndoFound says it's in fact a ...

MSK Breast Medical Oncologist Sherry Shen, MD, is an expert in the relationship between obesity, diet, and cancer. Her research includes studying new weight loss drugs such as Zepbound, Wegovy, and ...